Visual Feedback Reach Training for Ataxia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if special reach training with visual feedback can improve arm movements in people with ataxia, a condition affecting balance and coordination. Researchers are comparing two methods: one where participants see their hand's position while reaching and another where they receive simple success or failure feedback afterward. Individuals with cerebellar damage from a stroke, tumor, or degeneration who experience coordination issues may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to understanding innovative training methods that could enhance coordination in individuals with ataxia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that reach training with visual feedback is safe for improving reaching movements in people with ataxia?
Research on visual feedback reach training has shown it to be generally safe. Studies involving both healthy individuals and those with conditions like stroke have not reported major safety issues. Participants in these studies performed similar training exercises and managed them well. Although specific information on side effects is not available, the overall evidence suggests that the training is well-tolerated. This is encouraging for those considering participation in clinical trials using this method.12345
Why are researchers excited about this trial?
Researchers are excited about the reach training with visual feedback for ataxia because it offers a unique approach to improving motor control. Unlike traditional physical therapy that focuses on repetitive exercises, this method uses technology to provide immediate visual feedback, helping patients understand and adjust their movements more precisely. The treatments include two types of training: one with continuous visual guidance via a cursor and another that uses binary feedback to encourage learning through reinforcement. This innovative method not only aims to enhance coordination but also empowers patients to actively participate in their rehabilitation, potentially accelerating progress.
What evidence suggests that this trial's treatments could be effective for ataxia?
Research has shown that special training exercises with visual feedback can improve arm movements in people with ataxia, a condition affecting balance and coordination. In this trial, participants will engage in different training methods. Specifically, studies have found that reinforcement training, one method in this trial, where participants receive simple feedback on their performance, can reduce movement mistakes in patients with cerebellar damage. This method provides feedback after each attempt, allowing patients to adjust their movements over time. Another method in this trial is traditional reach training, where participants continuously see their hand position, which helps improve their aim. Both methods aim to make reaching movements more accurate and controlled.12567
Who Is on the Research Team?
Amy J Bastian, PhD, PT
Principal Investigator
Kennedy Krieger Institute and Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals aged 22-80 with cerebellar ataxia due to stroke, tumor, or degeneration. It's not suitable for those with extrapyramidal symptoms, vestibular loss, sensory neuropathy, significant pain or dementia (Mini-Mental State exam score > 22), vision loss affecting task performance, or damage to brain areas outside the cerebellum.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo reinforcement or standard practice training for reaching movements over a 12-week period
Rest Period
Participants have a rest period between training phases
Follow-up
Participants are monitored for retention of training effects
What Are the Treatments Tested in This Trial?
Interventions
- Reach training with visual feedback
Trial Overview
The study tests a reinforcement-based training method against standard practices over several weeks to improve reaching movements in people with ataxia. Participants will receive reach training that includes visual feedback.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Reach training with visual feedback. During each training session, participants will first be familiarized with the task and then will reach from a home position to 4 virtual targets that are presented in the front of the participant and within the workspace where most natural arm movements are performed. During training the participant will reach a total of 400 times. For standard practice, participants will be able to see a cursor that represents the position of the hand at all times and try to make straight reaches to the targets. This type of feedback provided specific information about the location of the hand.
Reach training with visual feedback. During each training session, participants will first be familiarized with the task and then will reach from a home position to 4 virtual targets that are presented in the front of the participant and within the workspace where most natural arm movements are performed. During training the participant will reach a total of 400 times. For reinforcement training, participants will not see their hand or a cursor, but instead participants will receive target-specific binary feedback after each reach (i.e. based on running average of last 10 reaches to that target). Binary feedback indicates only whether the reach was successful or unsuccessful and provides no specific information about the location of the hand.
Reach training with visual feedback is already approved in United States for the following indications:
- Cerebellar ataxia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
National Institutes of Health (NIH)
Collaborator
Published Research Related to This Trial
Citations
Visual Feedback Reach Training for Ataxia
This trial compares two training methods to improve arm movements in people with cerebellar ataxia. It targets individuals who struggle with movement ...
NCT03879018 | Retraining Reaching in Cerebellar Ataxia
Reach training with visual feedback. During each training session, participants will first be familiarized with the task and then will reach from a home ...
Reinforcement signaling can be used to reduce elements of ...
Our results suggest that binary reinforcement training can improve reaching movements in patients with cerebellar damage.
Effectiveness of Vestibular Rehabilitation for Patients with ...
This systematic review identified evidence for improvements with traditional physical and occupational therapy, as well as intensive ...
5.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT03879018/retraining-reaching-in-cerebellar-ataxia?id=829&slug=Friedreich's%20AtaxiaRetraining Reaching in Cerebellar Ataxia
The purpose of this study is to test for benefits of reinforcement based training paradigm versus standard practice over weeks for improving ...
Top Cerebellar Ataxia Clinical Trials | Power
Visual Feedback Reach Training for Ataxia. Baltimore, Maryland. This trial compares two training methods to improve arm movements in people with cerebellar ...
Preliminary Study of Vibrotactile Feedback during Home ...
Vibrotactile SA may be a beneficial addition to training regimens for individuals with hereditary cerebellar ataxia, but additional research ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.